Explore Our History

Established in 2005 through the merger of Daiichi Pharmaceutical and Sankyo, Daiichi Sankyo has a rich history spanning more than 100 years.

1915

1945

  • 1949

    Listed on Tokyo Stock Exchange

  • 1952

    Launched Iscotin®, a medicine for tuberculosis

  • 1965

    Completed construction of head office building in Nihonbashi, Japan

  • 1965

    Launched Transamin®, an antiplasmin medicine

  • 1966

    Launched Patecs®, the first form-fitting pain relief patch

  • 1973

    Launched Karoyan®, a hair restoration agent

1975

  • 1979

    Launched Neuer®, a peptic ulcer agent

  • 1981

    Established plant in Akita, Japan

  • 1983

    Signed out-licensing agreement for Tarivid®, a broad-spectrum antibacterial agent, with Johnson & Johnson of the United States and Hoechst of Germany

  • 1985

    Launched natural-type interferon-β formulation Feron®

  • 1985

    Launched Tarivid® in Japan and then-West Germany

  • 1987

    Launched Omnipark®, a contrast media

  • 1987

    Launched Senlock Pellet® (now Daiichi Sankyo Core Block®), a gastrointestinal agent

  • 1990

    Established Korea Daiichi Pharmaceutical Co., Ltd.

  • 1993

    Launched Cravit®, a broad-spectrum oral antibacterial agent

  • 1994

    Launched Kuromaru Drink®, a digestive tonic

  • 1998

    Established Daiichi Pharmaceutical (Beijing) Co., Ltd. in China

  • 2003

    Launched Cystina C®, an over-the-counter vitamin C product

2005-Today
History of Daiichi Sankyo Co., Ltd.